By Kathryn Hardison

Vertex Pharmaceuticals Inc.'s board of directors has approved a new share repurchase program for up to $3 billion of common stock.

The program doesn't have an expiration date and can be discontinued at any time, the company said Tuesday.

The board approved the new program on Feb. 1.

Write to Kathryn Hardison at kathryn.hardison@wsj.com

(END) Dow Jones Newswires

February 07, 2023 16:22 ET (21:22 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Vertex Pharmaceuticals (NASDAQ:VRTX)
過去 株価チャート
から 7 2024 まで 8 2024 Vertex Pharmaceuticalsのチャートをもっと見るにはこちらをクリック
Vertex Pharmaceuticals (NASDAQ:VRTX)
過去 株価チャート
から 8 2023 まで 8 2024 Vertex Pharmaceuticalsのチャートをもっと見るにはこちらをクリック